James A Johnson's Net Worth

$1.4 Million

Estimate Recalculated Oct 3, 2024 08:52PM EST

Who is James A Johnson?

James A Johnson has an estimated net worth of $1.4 Million. This is based on reported shares across multiple companies, which include ZYMOGENETICS INC, NanoString Technologies Inc, and Athira Pharma, Inc..

SEC CIK

James A Johnson's CIK is 0001225501

Past Insider Trading and Trends

2009 was James A Johnson's most active year for acquiring shares with 9 total transactions. James A Johnson's most active month to acquire stocks was the month of December. 2009 was James A Johnson's most active year for disposing of shares, totalling 9 transactions. James A Johnson's most active month to dispose stocks was the month of November. 2010 saw James A Johnson paying a total of $55,540.00 for 89,000 shares, this is the most they've acquired in one year. In 2010 James A Johnson cashed out on 66,019 shares for a total of $448,685.25, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ZYMOGENETICS INC No price found

Executive VP and CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-26.02K
$9.75
-$253,685.25
0
Oct 8
Form 4
—
0
$6.27
-$139,460.00
26.02K
Sep 8
Form 4
—
0
—
—
0
Jan 29
Form 4
—
0
—
—
0
Dec 16
Form 4
—
0
$4.89
-$42,223.00
26.02K
Dec 7
Form 4
—
0
$4.39
-$32,223.00
26.02K
Aug 31
Form 4
—
0
—
—
0
May 15
Form 4
—
0
—
—
0
Jan 30
Form 4
—
0
—
—
0
Jan 18
Form 4
+0.39%
100
—
—
26.02K
Jan 17
Form 4
—
0
—
—
0
Jul 2
Form 4
—
0
—
—
0
Jan 5
Form 4
-10.37%
-3.00K
$20.04
-$60,120.00
25.92K
Aug 24
Form 4
-9.40%
-3.00K
$21.75
-$65,250.00
28.92K
Mar 13
Form 4
—
0
$12.72
-$198,823.00
31.92K
Jan 12
Form 4
-8.59%
-3.00K
$20.01
-$60,030.00
31.92K
Jan 9
Form 4
-7.91%
-3.00K
$18.00
-$54,000.00
34.92K
Jan 5
Form 4
-7.33%
-3.00K
$18.00
-$54,000.00
37.92K
May 17
Form 4
-6.83%
-3.00K
$19.59
-$58,775.00
40.92K
Feb 14
Form 4
—
0
—
—
0
Jan 26
Form 4
—
0
$12.84
-$100,600.00
45.42K
Dec 15
Form 4
-15.89%
-8.58K
$18.15
-$155,745.15
45.42K
Jun 29
Form 4
—
0
—
—
0
Jan 7
No matching records found

NanoString Technologies Inc (NSTG) No price found

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+7.47%
594
$13.20
$7,840.80
8.55K
Sep 1
Form 4
+8.47%
621
$12.16
$7,548.25
7.95K
Mar 1
Form 4
+44.10%
2.24K
$18.80
-$20,473.20
7.33K
Feb 6
Form 4
—
0
$13.85
-$174,454.54
5.09K
Scheduled
Nov 10 - Nov 11
Form 4
+13.87%
620
$12.16
$7,539.20
5.09K
Sep 1
Form 4
+20.49%
760
$9.52
$7,235.20
4.47K
Mar 1
Form 4
—
0
—
—
0
Feb 3 - Feb 5
Form 4
+25.81%
761
$9.52
$7,244.72
3.71K
Sep 1
Form 4
+36.54%
789
$9.52
$7,511.28
2.95K
Mar 2
Form 4
—
0
—
—
0
Feb 9
Form 4
+96.99%
1.06K
$6.62
$7,038.65
2.16K
Sep 2
Form 4
∞
1.1K
$6.62
$7,257.16
1.1K
Mar 3
Form 4
—
0
—
—
0
Jan 31
Form 3
—
0
—
—
0
No matching records found

Athira Pharma, Inc. (ATHA) Snapshot price: $0.5407

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
May 19
Form 4
∞
5K
$2.40
$12,000.00
5K
Mar 29
Form 4
—
0
—
—
0
May 20
Form 4
—
0
—
—
0
May 28
Form 3
—
0
—
—
0
No matching records found